Neuropathic pain refers to pain caused by damage or disease to the nervous system.Neuropathic pain differs in pattern from ...

A new study by Monash University medicine safety experts found the use of gabapentinoids—medicines widely used to treat ...

Although systematic reviews have outlined the current treatment options for neuropathic pain, subsequent trials have necessitated an update of the NUMBER NEEDED TO TREAT (NNT) values presented in ...

A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to treat neuropathic pain -- increased the risk of hip fractures, especially in older patients who were ...

Nov. 13, 2024 — A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to treat neuropathic pain -- increased the risk of hip fractures, especially in ...

A new study from Monash University in Australia has found that gabapentinoids—commonly used drugs for treating neuropathic ...

The resulting paper, “ Clinical study of a micro-implantable pulse generator for the treatment of peripheral neuropathic pain ...

A new study by Monash University medicine safety experts found the use of gabapentinoids – medicines widely used to treat neuropathic pain – increased the risk of hip fractures, especially in ...

After acquiring the US rights to Qutenza in 2018, Grünenthal re-launched the product, which initially was approved for treating neuropathic pain associated with postherpetic neuralgia.

Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 clinical study, ...

Ayotunde Fadayomi has joined the Saint Francis Pain Management Center. He specializes in treating numerous types of pains.